Overview

Effect of IV Infusion of Lidocaine Compared to IV Infusion of Dexmedetomidine on Proinflammatory Cytokines

Status:
Completed
Trial end date:
2020-06-13
Target enrollment:
Participant gender:
Summary
This study is designed to compare between intravenous infusion of dexmedetomidine and intravenous infusion of lidocaine in reduction of proinflammatory cytokines as IL-6 and TNF-α, some stress reactions (serum insulin and serum lactate),and postoperative analgesic requirements in patients undergoing surgery for pelviabdominal cancers.
Phase:
Phase 3
Details
Lead Sponsor:
National Cancer Institute, Egypt
Norma Osama Abdalla Zayed
Collaborator:
Abdelhamid, Bassant Mohamed, M.D.
Treatments:
Dexmedetomidine
Lidocaine